Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 739 Records) |
Query Trace: Breast Neoplasms and Tp53[original query] |
---|
Frequency of genetic alterations differs in advanced breast cancer between metastatic sites. Genes, chromosomes & cancer 2023 9 . Isabel Grote, Alexandra Poppe, Ulrich Lehmann, Matthias Christgen, Hans Kreipe, Stephan Barte |
Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study. Asian Pacific journal of cancer prevention : APJCP 2023 9 24 (9): 3065-3075. Kailas D Datkhile, Rashmi A Gudur, Suresh J Bhosale, Pratik P Durgawale, Nilam J Jagdale, Ashwini L More, Anand K Gudur, Satish R Pat |
Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. Medicine 2023 9 102 (38): e35267. Jin Hyuk Choi, Jesang Yu, Minjung Jung, Junyong Jekal, Ku Sang Kim, Sung Ui Ju |
Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients. Breast cancer research and treatment 2023 8 . Aysun Dauti Isiklar, Lamiya Aliyeva, Ahmet Yesilyurt, Aykut Soyder, Gul Basar |
Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer. Scientific reports 2023 8 13 (1): 13542. Liye Wang, Shuai Gong, Lina Pang, Shengli Zhang, Xiaoke Zhang, Wei |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. Cells 2023 8 12 (15): . Aurora Gómez-Vecino, Roberto Corchado-Cobos, Adrián Blanco-Gómez, Natalia García-Sancha, Sonia Castillo-Lluva, Ana Martín-García, Marina Mendiburu-Eliçabe, Carlos Prieto, Sara Ruiz-Pinto, Guillermo Pita, Alejandro Velasco-Ruiz, Carmen Patino-Alonso, Purificación Galindo-Villardón, María Linarejos Vera-Pedrosa, José Jalife, Jian-Hua Mao, Guillermo Macías de Plasencia, Andrés Castellanos-Martín, María Del Mar Sáez-Freire, Susana Fraile-Martín, Telmo Rodrigues-Teixeira, Carmen García-Macías, Julie Milena Galvis-Jiménez, Asunción García-Sánchez, María Isidoro-García, Manuel Fuentes, María Begoña García-Cenador, Francisco Javier García-Criado, Juan Luis García-Hernández, María Ángeles Hernández-García, Juan Jesús Cruz-Hernández, César Augusto Rodríguez-Sánchez, Alejandro Martín García-Sancho, Estefanía Pérez-López, Antonio Pérez-Martínez, Federico Gutiérrez-Larraya, Antonio J Cartón, José Ángel García-Sáenz, Ana Patiño-García, Miguel Martín, Teresa Alonso-Gordoa, Christof Vulsteke, Lieselot Croes, Sigrid Hatse, Thomas Van Brussel, Diether Lambrechts, Hans Wildiers, Hang Chang, Marina Holgado-Madruga, Anna González-Neira, Pedro L Sánchez, Jesús Pérez Losa |
Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis. Journal of breast cancer 2023 8 . Xiao-Yi Lin, Lijuan Guo, Xin Lin, Yulei Wang, Guochun Zha |
Screening Practices for Breast and Nonbreast Cancers in High-Risk Mutation Carriers. The Journal of surgical research 2023 7 291 388-395. Alison C Coogan, Lilia G Lunt, Sarah S Keshwani, Olivia Sandhu, Yanyu Zhang, Cristina O'Donoghue, Andrea Madrigra |
Genetic and clinical landscape of ER?+?/PR- breast cancer in China. BMC cancer 2023 12 23 (1): 1189. Danian Dai, Hongmei Wu, Hongkai Zhuang, Rong Chen, Cheng Long, Bo Ch |
A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family. The oncologist 2023 12 . Xiling Yang, Li Shang, Liren Yang, Landi Sun, Xiaoqian Tuo, Sijia Ma, Le Zhao, Xu Li, Wenfang Ya |
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers. Breast cancer research and treatment 2023 12 . Melody A Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J Hockenberry, Abde M Abukhde |
Association of ESR1 germline variants with TP53 somatic variants in breast tumors in a genome-wide study. medRxiv : the preprint server for health sciences 2023 12 . Nijole P Tjader, Abigail J Beer, Johnny Ramroop, Mei-Chee Tai, Jie Ping, Tanish Gandhi, Cara Dauch, Susan L Neuhausen, Elad Ziv, Nereida Sotelo, Shreya Ghanekar, Owen Meadows, Monica Paredes, Jessica Gillespie, Amber Aeilts, Heather Hampel, Wei Zheng, Guochong Jia, Qiang Hu, Lei Wei, Song Liu, Christine B Ambrosone, Julie R Palmer, John D Carpten, Song Yao, Patrick Stevens, Weang-Kee Ho, Jia Wern Pan, Paolo Fadda, Dezheng Huo, Soo-Hwang Teo, Joseph Paul McElroy, Amanda Ewart Tola |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer. BMC medicine 2023 12 21 (1): 493. Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong |
Mutational Landscape and In-Silico Analysis of TP53, PIK3CA, and PTEN in Patients with Breast Cancer from Khyber Pakhtunkhwa. ACS omega 2023 11 8 (45): 43318-43331. Hilal Ahmad, Asif Ali, Roshan Ali, Ali Talha Khalil, Ishaq Khan, Mah Muneer Khan, Mohammed Alori |
Detection of TP53 gene mutation in blood of breast cancer patients based on circulating tumor DNA and its application in prognosis. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 200-206. Qiran Lu, Luxin Wei, Shenbin Cai, Zhe Zhang, Lifeng Zha |
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. Signal transduction and targeted therapy 2023 11 8 (1): 429. Yiqun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe |
Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease. Gene 2023 11 147980. Ashish Singh, Josh Thomas Georgy, Sakthi Dhananjayan, Elanthenral Sigamani, Ajoy Oommen John, Anjana Joel, Jagan Chandramohan, Rajadurai Abarna, Grace Rebekah, Selvamani Backianathan, Deepak Thomas Abraham, Mazhuvanchary Jacob Paul, Raju Titus Chacko, Marie Therese Manipadam, Rekha P |
The evaluation of the possibility of Li-Fraumeni syndrome in cancer patients in East Azarbaijan Province of Iran. Nucleosides, nucleotides & nucleic acids 2023 10 1-10. Maryam Esmaeilzadeh Aghjeh, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh, Abbas Ali Hosseinpour Feizi, Nasser Poula |
Investigation of Genetic Factors and Clinical Data in Breast Cancer Highlights the Importance of Breastfeeding and Cancer History. Current issues in molecular biology 2023 10 45 (10): 7933-7943. Amanda Mercês, Rebecca da-Silva-Cruz, Caio S Silva, Rommel Burbano, Ândrea Ribeiro-Dos-Santos, Giovanna C Cavalcan |
Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases. Journal of personalized medicine 2024 4 14 (4): . Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Duygu Gurel, Nurten Akdeniz, Ibrahim Meteog |
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 2024 4 8 e2300647. Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwa |
Genetic contribution of breast cancer genes in women of black African origin. Frontiers in genetics 2024 1 14 1302645. Rokhaya Ndiaye, Jean Pascal Demba Diop, Ahmadou Dem, Alioune Die |
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 1 JCO2301071. Stefania Morganti, Christopher J Gibson, Qingchun Jin, Katheryn Santos, Ashka Patel, Alex Wilson, Margaret Merrill, Julie Vincuilla, Samantha Stokes, Marla Lipsyc-Sharf, Tonia Parker, Tari A King, Elizabeth A Mittendorf, Giuseppe Curigliano, Melissa E Hughes, Daniel G Stover, Sara M Tolaney, Lachelle D Weeks, Nabihah Tayob, Nancy U Lin, Judy E Garber, Peter G Miller, Heather A Parso |
Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cancer. Clinical Medicine Insights. Oncology 2024 1 18 11795549231219239. Yanping Li, Wenfei Du, Rui Yang, Xiaonan Wei, Haibin Li, Xiaoyuan Zha |
Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets. Journal of thoracic disease 2024 1 15 (12): 6796-6805. Wen Ouyang, Jing Yu, Zihang Zeng, Jun Gong, Junhong Zhang, Conghua X |
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments. BMC cancer 2024 1 24 (1): 85. Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Naka |
BRCA2, PALB2, RECQL4 Germline Pathogenic Variants, and Somatic TP53 Mutation in Triple Metachronous Malignancies: A Case Report and Literature Review. International medical case reports journal 2024 1 17 23-29. Yang Liu, Hui Yang, Xueshu Fu, Luting Zhong, Ping Xu, Fang Fang, Ying Liu, Qing Li, Ya'nan Yan, Shanchuang Wei, Junqing Wang, Chunhua Zha |
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology, research and practice 2024 1 254 155075. Seref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Busra Kurt Gültaslar, Demet Akdeniz Odemis, Mukaddes Avsar, Fatma Sen, P?nar Mualla Saip, Hulya Yazi |
Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy. Genome medicine 2024 1 16 (1): 11. Gengshen Yin, Liyuan Liu, Ting Yu, Lixiang Yu, Man Feng, Chengjun Zhou, Xiaoying Wang, Guoxin Teng, Zhongbing Ma, Wenzhong Zhou, Chunmiao Ye, Jialin Zhang, Changhua Ji, Linfeng Zhao, Peng Zhou, Yaxun Guo, Xingchen Meng, Qinye Fu, Qiang Zhang, Liang Li, Fei Zhou, Chao Zheng, Yujuan Xiang, Mingming Guo, Yongjiu Wang, Fei Wang, Shuya Huang, Zhigang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: